2026 doctoral scholarship in pharmaceutical sciences - The Morris and Rosalind Goodman Family Foundation
The Morris and Rosalind Goodman Family Foundation scholarship program, established in 2023, aims to attract exceptional candidates from Québec, Canada, and abroad who wish to pursue a doctorate in pharmaceutical sciences at Université Laval’s Faculty of Pharmacy.
This prestigious scholarship supports innovative research projects along the entire pharmaceutical continuum, from the discovery of new drugs to their optimal use in the general population.
Deadlines | Decembre 7, 2026
Scholarship amount and duration
Amount: CAN$100,000 (CAN$12,500 per semester, or CAN$37,500 per year)
Duration: Up to eight semesters
Additional funding for extra semesters may be provided by the research supervisor, if necessary.
Eligibility
The scholarship is open to students who have been accepted into the pharmaceutical sciences or pharmacoepidemiology doctoral programs for the winter, summer, or fall 2027 semesters.
In order to be eligible for the scholarship, candidates must find a professor in the Faculty of Pharmacy willing to supervise their doctoral dissertation.
Eligibility is contingent on supervisor acceptance.
The Goodman scholarship is open to international students.
Research areas
The program covers all areas of pharmaceutical science in which the Faculty’s research teams are active, including:
- Nanotechnologies
- Drug formulation
- Drug target discovery
- Pharmacogenomics
- Repurposing of off-patent drugs
- Applied pharmacokinetics for bioequivalence testing
- Population health
- Drug quality risk assessment
- Pharmacoeconomics
- Health information technologies and policies
- Radiopharmacy and theranostics
Recipients
Pursuing a doctorate at the Faculty of Pharmacy
To be eligible for the Goodman scholarship, you must be enrolled in the pharmaceutical sciences or pharmacoepidemiology doctoral programs.
These programs offer:
- Personalized guidance from internationally recognized research teams
- A multidisciplinary scientific environment
- State-of-the-art research facilities
- Access to an extensive network of national and international partnerships